Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Toyota Global Sales Fall as China Demand Slumps 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Faraday Future Delivers First Robots in Middle East, Plans September Launches 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
CIA-Linked Investor Helped Quantum Systems Expand in US 
Add as a preferred source on Google
HORSHAM, Pa., March 29, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Monday, April 2, before the market opens. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 8:30 am Eastern Time to review the Company’s progress.
| Conference Call Details: | |
| Date: | Monday, April 2 |
| Time: | 8:30 am Eastern Time |
| Toll Free: | 888-394-8218 |
| International: | 323-794-2149 |
| Passcode: | 6380302 |
| Webcast: | www.strataskinsciences.com |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
| Investor Contacts: | |
| Frank McCaney, Chief Executive Officer | Bob Yedid, Managing Director |
| STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC |
| 215-619-3200 | 646-597-6989 |
| [email protected] | [email protected] |
